World's Best Scientists 2026 revealed!
International Journal of Immunopathology and Pharmacology
H-index 10

International Journal of Immunopathology and Pharmacology

0394-6320

Published by: SAGE

https://journals.sagepub.com/home/iji

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 242 9 9 3

Additional Metrics

Number of Best Scientists*: 50
Documents by Best Scientists*: 46
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 67
SCIMAGO SJR: 0.663
Impact Factor: 2.6

Overview

Top Research Topics at International Journal of Immunopathology and Pharmacology?

International Journal of Immunopathology and Pharmacology covers a variety of subjects, including Immunology, Internal medicine, Immune system, Pathology and Endocrinology. Research on Immunology presented in International Journal of Immunopathology and Pharmacology focuses, in particular, on Inflammation, Cytokine, Antibody, Immunoglobulin E and Antigen. Internal medicine research presented in the journal encompasses a variety of subjects, including Gastroenterology, Oncology and Cardiology.

The works on Pathology deal in particular with Immunohistochemistry.

  • Immunology (26.50%)
  • Internal medicine (20.80%)
  • Immune system (9.74%)

What are the most cited papers published in the journal?

  • Photodynamic Therapy Targeted to Pathogens (297 citations)
  • MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. (193 citations)
  • Visiting a Forest, but Not a City, Increases Human Natural Killer Activity and Expression of Anti-Cancer Proteins: (179 citations)

Research areas of the most cited articles at International Journal of Immunopathology and Pharmacology:

The journal publications cover a variety of subjects, including Immunology, Internal medicine, Inflammation, Cell biology and Pathology. Immune system, Cytokine, Tumor necrosis factor alpha, Proinflammatory cytokine and Antigen are some of the study areas of Immunology discussed in the published papers. The works on Internal medicine tackled in the most cited publications bring together disciplines like Gastroenterology, Psoriasis and Endocrinology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

The journal is mainly concerned with subjects like Internal medicine, Cancer research, Immunology, Immune system and Disease. It holds forums on Internal medicine that merges themes from other disciplines such as Gastroenterology and Diabetes mellitus, Endocrinology. The concepts on Cancer research presented in the journal can also apply to other research fields, including Cancer, Metastasis, RNA, Histone deacetylase inhibitor and Cytotoxic T cell.

Aside from research in Immunology, it also discusses In patient studies. It facilitates discussions on Immune system that incorporate concepts from other fields like Inflammation and Liver injury, Pharmacology. Issues in Disease were discussed, taking into consideration concepts from other disciplines like Platelet activation and Serology.

The most cited articles from the last journal are:

  • SARS-CoV-2 (COVID-19) and audio-vestibular disorders. (2 citations)
  • Activation of RAW264.7 cells by PCp-I, a polysaccharide from Psoralea corylifolia L, through NF-κB/MAPK signalling pathway. (2 citations)
  • Immuno-modulation by heat-killed Lacticaseibacillus paracasei MCC1849 and its application to food products: (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in International Journal of Immunopathology and Pharmacology (based on the number of publications) are:

  • M. Di Gioacchino (42 papers) absent at the last edition,
  • Theoharis C. Theoharides (39 papers) absent at the last edition,
  • Francesco Carinci (38 papers) absent at the last edition,
  • Pio Conti (35 papers) absent at the last edition,
  • Giorgio Ciprandi (34 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in International Journal of Immunopathology and Pharmacology (based on the number of publications) are:

  • Sapienza University of Rome (269 papers) absent at the last edition,
  • University of Chieti-Pescara (202 papers) absent at the last edition,
  • University of Pavia (94 papers) published 1 paper at the last edition,
  • University of Rome Tor Vergata (93 papers) absent at the last edition,
  • University of Milan (85 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 10.45% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 1.67% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 26.67% of all publications and 66.67% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Positron emission tomography and single photon emission computed tomography imaging of tertiary lymphoid structures during the development of lupus nephritis

    (2021)
    10 Citations
  • Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

    (2023)
    4 Citations
  • MUC1 expressing tumor growth was retarded after human mucin 1 (MUC1) plasmid DNA immunization

    (2022)
    3 Citations
  • Expression of cPLA2γ mRNA and protein differs the response of PBMC from severe and non-severe asthmatics to bacterial lipopolysaccharide and house dust mite allergen.

    Ewa Pniewska-Dawidczyk;Izabela Kupryś-Lipińska;Gabriela Turek;Dorota Kacprzak

    (2021)
    2 Citations
  • Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway

    (2024)
    2 Citations
  • Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab

    (2022)
    2 Citations
  • A case of late-onset larynx angioedema after ranibizumab intravitreal injection: Ranibizumab-related angioedema.

    Maddalena De Bernardo;Cristiana Stellato;Nicola Rosa;Ilaria De Pascale

    (2020)
    1 Citations
  • Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency

    Silvia Ricci;Francesca Lippi;Clementina Canessa;Chiara Guarnieri

    (2020)
    1 Citations
  • Mapping the psoriasis research landscape: A comprehensive bibliometric analysis from 2012-2023

    (2024)
    0 Citations

Best Scientists Contributing to This Journal

Recently Published Articles